AKRO — Akero Therapeutics Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk
Brief: Akero Therapeutics Presents New Phase 2b Trial Data On Efruxifermin At AASLD Liver Meeting 2025
Analysis: Novo Nordisk changes tack with bold raid on Pfizer obesity deal
U.S. RESEARCH ROUNDUP- American Express, BlackRock, Domino's Pizza
Brief: Akero Says If Deal Terminated, Co To Pay $165 Million Termination Fee To Novo Nordisk
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation
Akero Therapeutics rises on up to $5.2 billion buyout deal from Novo
Deals of the day-Mergers and acquisitions
Novo Nordisk’s liver deal misses bigger ailment
U.S. STOCKS ON THE MOVE-Whirlpool, IREN, Cidara
U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air Lines
Novo Nordisk shares fall on 'costly' Akero Therapeutics acquisition
Akero Therapeutics rises after Novo's up to $5.2 billion buyout deal
Brief: Akero Therapeutics To Be Acquired By Novo Nordisk For Up To $5.2 Billion
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion (updated)